,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Neutropenia,6,16453765
1,22.0,Monocyte percentage increased,6,16453765
2,22.0,Haematocrit decreased,6,16453765
3,22.0,Mean cell haemoglobin concentration,6,16453765
4,22.0,Red cell distribution width increased,6,16453765
5,22.0,Mean cell volume decreased,6,16453765
6,22.0,Platelet count increased,1,16453765
7,22.0,Blood urea increased,6,16453765
8,22.0,Mean cell haemoglobin decreased,6,16453765
9,22.0,Metastases to bone,6,16453765
10,22.0,Anaemia,6,16453765
11,22.0,Glomerular filtration rate decreased,6,16453765
12,22.0,Lymphocyte percentage increased,6,16453765
13,22.0,Blood alkaline phosphatase increased,1,16453765
14,22.0,Blood chloride increased,6,16453765
15,22.0,White blood cell count decreased,6,16453765
0,22.0,Paraneoplastic syndrome,6,16453786
1,22.0,Arthralgia,3,16453786
0,22.0,Tumour marker increased,6,16453809
1,22.0,Malignant neoplasm progression,6,16453809
2,22.0,Vomiting,1,16453809
3,22.0,Metastases to liver,6,16453809
4,22.0,Nausea,1,16453809
0,22.0,Pulmonary embolism,6,16453839
1,22.0,Rash,6,16453839
2,22.0,Nausea,6,16453839
0,22.0,Intentional dose omission,6,16453842
1,22.0,Breast pain,2,16453842
2,22.0,Bone pain,2,16453842
3,22.0,Back pain,2,16453842
0,22.0,Septic shock,5,16453870
1,22.0,Multiple organ dysfunction syndrome,5,16453870
0,22.0,Pleural effusion,1,16453876
1,22.0,Malignant neoplasm progression,6,16453876
2,22.0,Metastases to bone,6,16453876
3,22.0,Stomatitis,3,16453876
4,22.0,Dyspnoea,2,16453876
5,22.0,Pleural effusion,6,16453876
6,22.0,Asthenia,3,16453876
7,22.0,Breast cancer,6,16453876
0,22.0,Injection site haemorrhage,1,16453895
1,22.0,Cardiac disorder,6,16453895
0,22.1,Drug eruption,6,16453907
1,22.1,Malignant neoplasm progression,5,16453907
0,22.0,Diarrhoea,6,16453931
1,22.0,Peripheral swelling,3,16453931
2,22.0,Nausea,3,16453931
3,22.0,Blood creatinine increased,6,16453931
4,22.0,Haemoglobin decreased,6,16453931
0,22.0,Intentional product use issue,6,16453953
0,22.0,Graft versus host disease,6,16453966
1,22.0,Rash,6,16453966
2,22.0,Renal disorder,6,16453966
0,22.1,Neutrophil count decreased,1,16454027
1,22.1,Pulmonary haemorrhage,5,16454027
2,22.1,Nausea,6,16454027
3,22.1,Bone marrow failure,6,16454027
4,22.1,Leukopenia,1,16454027
5,22.1,Decreased appetite,6,16454027
6,22.1,Platelet count decreased,1,16454027
0,22.0,Osteoma cutis,6,16454036
0,22.0,Blood pressure increased,6,16454062
1,22.0,Malaise,6,16454062
2,22.0,Vomiting,6,16454062
0,22.0,Loss of consciousness,5,16454064
0,22.1,Myocardial infarction,1,16454095
1,22.1,Bone pain,2,16454095
2,22.1,Abdominal discomfort,3,16454095
0,22.0,Cholelithiasis,1,16454150
1,22.0,Hepatic function abnormal,1,16454150
2,22.0,Cholangitis,1,16454150
0,22.0,Metastases to bone,6,16454190
0,22.0,Hair disorder,3,16454204
1,22.0,Alopecia,3,16454204
2,22.0,Hair colour changes,3,16454204
3,22.0,Hair texture abnormal,3,16454204
4,22.0,Madarosis,3,16454204
0,22.0,Hypoxia,1,16454259
1,22.0,Hyperhidrosis,1,16454259
2,22.0,Back pain,1,16454259
3,22.0,Retching,1,16454259
4,22.0,Nausea,1,16454259
5,22.0,Flushing,1,16454259
0,22.0,Acute myocardial infarction,5,16454261
0,22.0,Bile duct stenosis,6,16454288
0,22.0,Dermatitis bullous,1,16454303
0,22.0,Drug ineffective,6,16454393
1,22.0,Aortitis,1,16454393
0,22.0,Glossitis,2,16454396
1,22.0,Stomatitis,2,16454396
2,22.0,Cheilitis,2,16454396
0,22.0,Pneumothorax,1,16454469
0,22.0,Vasculitis,2,16454484
0,22.1,Anaphylactic shock,1,16454500
1,22.1,Eosinophil count increased,3,16454500
0,22.0,Pulmonary embolism,6,16454552
1,22.0,Anaemia,6,16454552
2,22.0,Venous thrombosis limb,6,16454552
0,22.0,Death,5,16454566
0,22.0,Abdominal distension,1,16454577
1,22.0,Colitis microscopic,1,16454577
2,22.0,Diarrhoea,1,16454577
0,22.0,Neuropathy peripheral,1,16454579
1,22.0,Granulomatous lymphadenitis,6,16454579
0,22.0,Interstitial lung disease,1,16454673
1,22.0,Diarrhoea,1,16454673
0,22.0,Swelling of eyelid,6,16454682
1,22.0,Ear neoplasm,6,16454682
2,22.0,Salivary gland neoplasm,6,16454682
3,22.0,Myalgia,6,16454682
4,22.0,Headache,6,16454682
0,22.0,Dyspnoea,5,16454897
1,22.0,Pleural mass,5,16454897
2,22.0,Cardiomegaly,5,16454897
3,22.0,Chest X-ray abnormal,5,16454897
0,22.1,Memory impairment,2,16454935
1,22.1,Dyspepsia,2,16454935
2,22.1,Cognitive disorder,3,16454935
3,22.1,Cough,2,16454935
4,22.1,Fatigue,3,16454935
5,22.1,Neuropathy peripheral,3,16454935
6,22.1,Diarrhoea,1,16454935
7,22.1,Product dose omission,6,16454935
8,22.1,Neuralgia,6,16454935
9,22.1,Back pain,6,16454935
10,22.1,Dysphagia,3,16454935
11,22.1,Asthenia,3,16454935
12,22.1,Gastrooesophageal reflux disease,6,16454935
13,22.1,Nausea,3,16454935
14,22.1,Decreased appetite,3,16454935
0,22.0,Drug ineffective,6,16455003
1,22.0,Neutropenia,6,16455003
2,22.0,Thrombocytopenia,6,16455003
3,22.0,Performance status decreased,6,16455003
4,22.0,Fatigue,6,16455003
5,22.0,Disease progression,6,16455003
0,22.1,Skin disorder,1,16455230
1,22.1,Malignant neoplasm progression,6,16455230
2,22.1,Febrile neutropenia,1,16455230
3,22.1,Tumour lysis syndrome,1,16455230
4,22.1,Immune thrombocytopenic purpura,1,16455230
5,22.1,Hiccups,1,16455230
0,22.0,Rash,3,16455234
1,22.0,Product use in unapproved indication,6,16455234
0,22.0,Dyspnoea,1,16455239
1,22.0,Product use in unapproved indication,6,16455239
0,22.0,Anaemia,1,16455244
1,22.0,Diarrhoea,1,16455244
2,22.0,Abdominal pain,1,16455244
0,22.0,Product use in unapproved indication,6,16455248
1,22.0,Gastric disorder,6,16455248
0,22.0,Rash,6,16455267
1,22.0,Product use in unapproved indication,6,16455267
0,22.0,Product use in unapproved indication,6,16455270
1,22.0,Rash generalised,6,16455270
0,22.0,Drug intolerance,6,16455273
1,22.0,Product use in unapproved indication,1,16455273
0,22.0,Product use in unapproved indication,6,16455275
1,22.0,Dehydration,6,16455275
0,22.0,Metastases to peritoneum,5,16455297
1,22.0,Malignant neoplasm progression,5,16455297
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16455297
3,22.0,Anaemia,2,16455297
4,22.0,Product use in unapproved indication,1,16455297
0,22.0,Diarrhoea,6,16455298
1,22.0,Vomiting,6,16455298
2,22.0,Abdominal pain,6,16455298
3,22.0,Product use in unapproved indication,6,16455298
0,22.0,Vomiting,6,16455300
1,22.0,Pain,6,16455300
2,22.0,Hallucination,6,16455300
3,22.0,Nausea,6,16455300
4,22.0,Fatigue,6,16455300
0,22.0,Cerebral haemorrhage,3,16455327
0,22.0,Headache,1,16455353
1,22.0,Vomiting,1,16455353
2,22.0,Diarrhoea,1,16455353
0,22.0,Erythema,1,16455356
1,22.0,Dyspnoea at rest,1,16455356
2,22.0,Back pain,1,16455356
0,22.0,Hypersensitivity,1,16455360
1,22.0,Off label use,6,16455360
0,22.0,Oesophageal perforation,6,16455426
0,22.1,Catheter site haemorrhage,6,16455427
1,22.1,Hyponatraemia,3,16455427
2,22.1,Bone marrow failure,1,16455427
3,22.1,Pyelonephritis,6,16455427
4,22.1,Anaemia,6,16455427
5,22.1,Febrile neutropenia,1,16455427
6,22.1,General physical health deterioration,6,16455427
0,22.1,Drug intolerance,6,16455458
1,22.1,Sepsis,2,16455458
2,22.1,Cancer pain,6,16455458
3,22.1,Malignant neoplasm progression,6,16455458
4,22.1,Metastasis,6,16455458
5,22.1,Therapeutic response decreased,6,16455458
6,22.1,Thrombocytopenia,2,16455458
7,22.1,Metastases to liver,6,16455458
8,22.1,Off label use,6,16455458
9,22.1,Invasive ductal breast carcinoma,6,16455458
10,22.1,Neutropenia,6,16455458
11,22.1,Hepatic failure,5,16455458
12,22.1,Haematotoxicity,1,16455458
0,22.0,Feeling abnormal,3,16455462
1,22.0,Red blood cell count decreased,3,16455462
2,22.0,Diarrhoea,3,16455462
3,22.0,Pneumonia,1,16455462
4,22.0,Headache,3,16455462
0,22.0,Disease progression,6,16455606
1,22.0,Death,5,16455606
0,22.0,Acute myeloid leukaemia,3,16455632
0,22.0,Anaphylactic reaction,1,16455636
1,22.0,Tachycardia,1,16455636
2,22.0,Bronchospasm,1,16455636
3,22.0,Erythema,1,16455636
4,22.0,Hypotension,1,16455636
5,22.0,Hypersensitivity,1,16455636
0,22.0,Breast cancer recurrent,6,16455737
0,22.0,Haematotoxicity,1,16455781
1,22.0,Neurotoxicity,1,16455781
0,22.0,Peripheral swelling,3,16455782
1,22.0,Drug ineffective,6,16455782
2,22.0,Pleural effusion,6,16455782
3,22.0,Drug resistance,6,16455782
0,22.0,Joint swelling,6,16455830
1,22.0,Oedema,6,16455830
0,22.0,Nausea,2,16455884
1,22.0,Abdominal distension,2,16455884
2,22.0,Carbohydrate antigen 125 increased,3,16455884
3,22.0,Discomfort,2,16455884
0,22.0,Neutropenia,1,16455895
0,22.0,Dermatitis acneiform,2,16455926
0,22.0,Acute myeloid leukaemia,3,16455963
0,22.0,Chylothorax,1,16455997
1,22.0,Ascites,1,16455997
2,22.0,Skin erosion,1,16455997
3,22.0,Proteinuria,1,16455997
0,22.0,Blood bilirubin abnormal,6,16455999
1,22.0,Blood alkaline phosphatase increased,6,16455999
2,22.0,Transaminases abnormal,6,16455999
3,22.0,Haemolytic uraemic syndrome,6,16455999
4,22.0,Anaemia,6,16455999
5,22.0,Renal impairment,6,16455999
6,22.0,Blood alkaline phosphatase abnormal,6,16455999
7,22.0,Blood bilirubin increased,6,16455999
0,22.1,Abscess rupture,5,16456094
1,22.1,Cholangitis,6,16456094
2,22.1,Chest pain,6,16456094
3,22.1,Pancreatic neoplasm,6,16456094
4,22.1,Metastases to liver,6,16456094
5,22.1,Peritonitis,5,16456094
6,22.1,Liver abscess,5,16456094
7,22.1,Tumour necrosis,6,16456094
8,22.1,Hepatic failure,6,16456094
9,22.1,Tumour rupture,6,16456094
0,22.0,Gastric infection,6,16456099
1,22.0,White blood cell count decreased,6,16456099
2,22.0,Diarrhoea,6,16456099
0,22.0,Acne,2,16456103
1,22.0,Skin haemorrhage,3,16456103
2,22.0,Eczema,6,16456103
3,22.0,Pruritus generalised,2,16456103
4,22.0,Infection,3,16456103
0,22.0,Hypersensitivity,2,16456112
0,22.0,Amnesia,6,16456124
1,22.0,Dementia,6,16456124
0,22.0,Death,5,16456126
0,22.0,Diarrhoea,6,16456135
0,22.0,Infection,6,16456147
0,22.0,Dyspnoea,6,16456148
1,22.0,Fatigue,6,16456148
2,22.0,Hypertension,6,16456148
3,22.0,Asthenia,6,16456148
0,22.0,Asthenia,1,16456181
1,22.0,Insomnia,1,16456181
2,22.0,Alopecia,1,16456181
3,22.0,Dysgeusia,1,16456181
4,22.0,Oedema peripheral,1,16456181
0,22.0,Muscle spasms,2,16456182
1,22.0,Paraesthesia,2,16456182
2,22.0,Constipation,2,16456182
3,22.0,Off label use,6,16456182
0,22.0,Oesophagitis,6,16456184
0,22.0,Pulmonary toxicity,6,16456186
0,22.0,Hyperhidrosis,2,16456200
1,22.0,Asthenia,2,16456200
2,22.0,Vomiting,2,16456200
3,22.0,Abdominal pain upper,2,16456200
4,22.0,Flushing,2,16456200
5,22.0,Erythema,2,16456200
6,22.0,Nausea,2,16456200
0,22.0,Death,5,16456202
0,22.0,Pulmonary fibrosis,1,16456210
1,22.0,Haematuria,1,16456210
2,22.0,Pulmonary mass,1,16456210
3,22.0,Dyspnoea,2,16456210
4,22.0,Dyspnoea exertional,1,16456210
0,22.1,Blood bilirubin increased,1,16456223
0,22.0,Decreased appetite,6,16456246
1,22.0,Dyspnoea,6,16456246
2,22.0,Hepatomegaly,6,16456246
3,22.0,Metastasis,6,16456246
4,22.0,Metastases to lung,6,16456246
5,22.0,Metastases to liver,6,16456246
6,22.0,Gastritis,3,16456246
7,22.0,Malaise,6,16456246
8,22.0,Death,5,16456246
9,22.0,Pleural effusion,6,16456246
10,22.0,Asthenia,6,16456246
0,22.0,Mucosal inflammation,6,16456251
0,22.0,Stevens-Johnson syndrome,2,16456256
0,22.0,Vomiting,2,16456293
1,22.0,Paraesthesia,2,16456293
2,22.0,Skin fissures,2,16456293
3,22.0,Asthenia,2,16456293
0,22.0,Chills,,16456307
0,22.0,Death,,16456331
0,22.0,Pruritus,,16456337
1,22.0,Dry skin,,16456337
0,22.0,Hypertension,,16456344
0,22.0,Cerebrovascular accident,6,16456349
1,22.0,Dysphagia,3,16456349
0,22.0,Brain operation,,16456351
1,22.0,Therapy cessation,,16456351
0,22.0,Erythema,1,16456359
1,22.0,Hypersensitivity,1,16456359
2,22.0,Bronchospasm,1,16456359
3,22.0,Hypotension,1,16456359
4,22.0,Anaphylactic reaction,1,16456359
5,22.0,Tachycardia,1,16456359
0,22.0,Hypertransaminasaemia,2,16456361
0,22.0,Pyelonephritis,1,16456366
1,22.0,Neutropenia,1,16456366
0,22.0,Anaemia,3,16456442
1,22.0,Duodenal ulcer haemorrhage,3,16456442
0,22.0,Abdominal pain,6,16456460
1,22.0,Abdominal distension,6,16456460
2,22.0,Gastrooesophageal reflux disease,6,16456460
3,22.0,Decreased appetite,6,16456460
4,22.0,Diarrhoea,6,16456460
5,22.0,Prostate cancer,5,16456460
6,22.0,Flatulence,6,16456460
7,22.0,Constipation,6,16456460
0,22.0,Blood sodium decreased,,16456474
0,22.0,Bone marrow failure,1,16456476
1,22.0,Neutropenia,1,16456476
0,22.0,Death,5,16456483
0,22.0,Death,5,16456496
0,22.0,Death,5,16456498
0,22.0,Death,5,16456502
0,22.0,Therapy cessation,,16456525
1,22.0,Hospitalisation,,16456525
0,22.0,Pneumonia bacterial,5,16456527
0,22.0,Respiratory failure,5,16456539
1,22.0,Haemorrhage,2,16456539
0,22.0,Metastases to central nervous system,6,16456549
0,22.0,Hepatitis,3,16456595
1,22.0,Nausea,3,16456595
2,22.0,Product use in unapproved indication,3,16456595
0,22.0,Dermatomyositis,,16456733
0,22.0,Transfusion,,16456804
1,22.0,Red blood cell count decreased,,16456804
0,22.0,Dehydration,4,16456827
1,22.0,Chronic kidney disease,4,16456827
0,22.1,Cough,3,16456892
1,22.1,Hypertension,2,16456892
2,22.1,Fatigue,3,16456892
0,22.0,Skin exfoliation,,16456894
0,22.0,Metastasis,3,16457013
1,22.0,Malignant neoplasm progression,3,16457013
2,22.0,Metastases to bone,3,16457013
0,22.0,Malignant neoplasm progression,6,16457014
1,22.0,Invasive breast carcinoma,6,16457014
2,22.0,Metastases to bone,6,16457014
3,22.0,Metastases to lymph nodes,6,16457014
0,22.0,Hepatic encephalopathy,1,16457277
1,22.0,Loss of consciousness,6,16457277
0,22.0,Venoocclusive liver disease,3,16457376
0,22.0,Death,5,16457384
0,22.0,Acute kidney injury,6,16457428
0,22.0,Adverse drug reaction,6,16457466
1,22.0,Urinary tract infection,6,16457466
2,22.0,Blood pressure increased,6,16457466
3,22.0,Migraine,6,16457466
0,22.0,Confusional state,2,16457468
1,22.0,Neurotoxicity,2,16457468
2,22.0,Delirium,2,16457468
3,22.0,Dysphagia,2,16457468
4,22.0,Somnolence,2,16457468
5,22.0,Hyperaesthesia,2,16457468
6,22.0,Emotional distress,2,16457468
7,22.0,Paradoxical pain,2,16457468
8,22.0,Agitation,2,16457468
9,22.0,Drug ineffective,6,16457468
0,22.0,Hypothalamo-pituitary disorder,1,16457472
1,22.0,White blood cell count increased,1,16457472
2,22.0,Blood creatinine increased,1,16457472
3,22.0,Hypercalcaemia,1,16457472
4,22.0,Hyponatraemia,1,16457472
0,22.0,Death,5,16457480
1,22.0,Pneumonia,6,16457480
0,22.0,Neoplasm progression,6,16457492
1,22.0,Product dose omission,6,16457492
2,22.0,Death,5,16457492
0,22.0,Bone marrow failure,2,16457517
0,22.0,Malignant pleural effusion,6,16457526
0,22.0,Lung disorder,6,16457534
0,22.0,Lung disorder,6,16457536
0,22.0,Liver disorder,3,16457543
1,22.0,Back pain,3,16457543
0,22.0,Ulcer,4,16457579
1,22.0,Fatigue,6,16457579
2,22.0,Nausea,1,16457579
3,22.0,Dehydration,2,16457579
4,22.0,Gastroenteritis viral,2,16457579
5,22.0,Vomiting,1,16457579
6,22.0,Haematemesis,1,16457579
7,22.0,Infection,6,16457579
8,22.0,Product dose omission,2,16457579
0,22.0,Neutropenic infection,5,16457581
0,22.0,Pancytopenia,1,16457600
1,22.0,Thrombocytopenia,6,16457600
2,22.0,Pyrexia,6,16457600
3,22.0,Peritonsillar abscess,1,16457600
4,22.0,Adverse event,6,16457600
5,22.0,Anaemia,6,16457600
6,22.0,Echocardiogram abnormal,6,16457600
7,22.0,Neuropathy peripheral,6,16457600
0,22.0,Death,5,16457609
0,22.0,Urinary retention,1,16457610
1,22.0,Cystitis,6,16457610
0,22.0,Death,5,16457612
0,22.0,Pruritus,2,16457633
1,22.0,Dehydration,1,16457633
2,22.0,Urinary tract infection,1,16457633
3,22.0,Rash pustular,1,16457633
4,22.0,Confusional state,1,16457633
0,22.0,Death,5,16457634
0,22.0,Death,5,16457637
0,22.1,Pleural effusion,6,16457643
1,22.1,Disease progression,6,16457643
2,22.1,Radiation pneumonitis,1,16457643
0,22.0,Death,5,16457648
0,22.0,Viral myelitis,,16457673
0,22.1,Concussion,6,16457697
1,22.1,Neoplasm progression,6,16457697
2,22.1,Cognitive disorder,6,16457697
3,22.1,Shoulder deformity,6,16457697
4,22.1,Feeling abnormal,6,16457697
5,22.1,Fall,6,16457697
6,22.1,Movement disorder,6,16457697
7,22.1,Body height decreased,6,16457697
8,22.1,Mental status changes,6,16457697
9,22.1,Disturbance in attention,6,16457697
0,22.0,Malaise,6,16457701
0,22.0,Drug effective for unapproved indication,6,16457734
1,22.0,Off label use,6,16457734
0,22.0,Leukopenia,1,16457742
1,22.0,Neutropenia,1,16457742
0,22.0,Dyspnoea,1,16457745
1,22.0,Sepsis,1,16457745
2,22.0,Tachycardia,6,16457745
3,22.0,Pneumonia,1,16457745
0,22.0,Blood calcium increased,6,16457819
1,22.0,Haemoglobin decreased,6,16457819
2,22.0,Blood magnesium decreased,6,16457819
3,22.0,Death,5,16457819
4,22.0,Pain,6,16457819
0,22.0,Acute kidney injury,3,16457820
1,22.0,Chronic kidney disease,3,16457820
2,22.0,End stage renal disease,3,16457820
0,22.0,Sepsis,5,16457824
0,22.0,Dyspnoea,6,16457874
1,22.0,Bradycardia,1,16457874
2,22.0,Asthma,6,16457874
3,22.0,Cough,6,16457874
4,22.0,Nasopharyngitis,6,16457874
5,22.0,Asthenia,6,16457874
6,22.0,Rhinitis,6,16457874
0,22.0,Spinal compression fracture,,16457883
0,22.0,Osteonecrosis of jaw,,16457885
0,22.0,Abdominal pain,1,16457927
1,22.0,Neutrophil count decreased,1,16457927
0,22.0,Bone marrow toxicity,1,16457929
0,22.0,Tendon rupture,4,16457935
0,22.0,Inguinal hernia,1,16457936
1,22.0,Foetal growth restriction,1,16457936
2,22.0,Foetal exposure during pregnancy,1,16457936
3,22.0,Neonatal respiratory distress syndrome,6,16457936
4,22.0,Low birth weight baby,1,16457936
5,22.0,Premature baby,1,16457936
0,22.1,Hyponatraemia,5,16457943
1,22.1,Hypochloraemia,5,16457943
2,22.1,Disease progression,5,16457943
0,22.1,Neoplasm progression,6,16457968
0,22.0,Death,5,16457975
0,22.0,White blood cell count decreased,4,16458022
1,22.0,Platelet count decreased,4,16458022
2,22.0,Pulmonary embolism,1,16458022
3,22.0,Deep vein thrombosis,1,16458022
4,22.0,Anaphylactic reaction,6,16458022
0,22.0,Death,5,16458047
0,22.0,Blood pressure increased,6,16458091
1,22.0,Nausea,3,16458091
2,22.0,Blood urine present,2,16458091
3,22.0,Colorectal cancer,3,16458091
4,22.0,Haemorrhage urinary tract,3,16458091
5,22.0,Metastases to liver,,16458091
6,22.0,Metastases to lymph nodes,,16458091
7,22.0,Faeces soft,3,16458091
8,22.0,White blood cells urine positive,,16458091
9,22.0,Fatigue,3,16458091
10,22.0,Drug ineffective,,16458091
11,22.0,Febrile neutropenia,,16458091
12,22.0,Dysphonia,3,16458091
13,22.0,Gingival bleeding,6,16458091
14,22.0,Epistaxis,3,16458091
0,22.0,Death,5,16458116
0,22.0,Oxygen saturation decreased,1,16458223
1,22.0,Hyperhidrosis,1,16458223
2,22.0,Erythema,1,16458223
3,22.0,Pruritus,1,16458223
4,22.0,Tachycardia,1,16458223
5,22.0,Infusion related reaction,1,16458223
6,22.0,Hypotension,1,16458223
0,22.0,Death,5,16458224
0,22.1,Hypoaesthesia,6,16458240
1,22.1,Dry mouth,6,16458240
2,22.1,Alopecia,6,16458240
3,22.1,Dry skin,6,16458240
4,22.1,Fatigue,6,16458240
5,22.1,White blood cell count decreased,6,16458240
0,22.0,Blood glucose increased,3,16458245
0,22.0,Blood creatinine increased,3,16458276
1,22.0,Platelet count decreased,2,16458276
2,22.0,Agranulocytosis,6,16458276
3,22.0,Aplastic anaemia,6,16458276
4,22.0,White blood cell count decreased,2,16458276
0,22.0,Liver function test increased,6,16458282
1,22.0,Alanine aminotransferase increased,6,16458282
2,22.0,Blood alkaline phosphatase increased,6,16458282
3,22.0,Aspartate aminotransferase increased,6,16458282
0,22.0,Febrile neutropenia,6,16458312
1,22.0,Diarrhoea,6,16458312
0,22.0,Hospitalisation,6,16458347
0,22.0,Oxygen therapy,6,16458382
1,22.0,Product use in unapproved indication,6,16458382
2,22.0,Adverse event,6,16458382
0,22.0,Polyneuropathy,6,16459049
1,22.0,Neutropenia,1,16459049
2,22.0,Nausea,6,16459049
3,22.0,Pruritus,6,16459049
0,22.0,Nephrotic syndrome,2,16459067
0,22.0,Jaundice cholestatic,6,16459081
0,22.0,Vertigo,1,16459094
1,22.0,Gait disturbance,1,16459094
2,22.0,Diplopia,1,16459094
3,22.0,Hypoaesthesia,1,16459094
4,22.0,Hypertension,1,16459094
5,22.0,Vomiting,1,16459094
0,22.0,Electrolyte imbalance,6,16459128
1,22.0,Coeliac disease,6,16459128
2,22.0,Acidosis,6,16459128
3,22.0,Diarrhoea,4,16459128
4,22.0,Gastrointestinal bacterial overgrowth,6,16459128
0,22.1,Neuropathy peripheral,6,16459142
1,22.1,Drug intolerance,6,16459142
2,22.1,Surgery,6,16459142
3,22.1,Malaise,2,16459142
4,22.1,Pallor,6,16459142
5,22.1,Dehydration,2,16459142
6,22.1,Cyst,6,16459142
7,22.1,Vomiting,3,16459142
8,22.1,Sunburn,6,16459142
9,22.1,Nausea,3,16459142
10,22.1,Fatigue,6,16459142
11,22.1,Insomnia,2,16459142
12,22.1,Dizziness,6,16459142
13,22.1,Asthenia,2,16459142
14,22.1,Computerised tomogram abnormal,6,16459142
15,22.1,Product dose omission,6,16459142
0,22.0,Neurological symptom,1,16459151
1,22.0,Liver disorder,1,16459151
2,22.0,Immune-mediated adverse reaction,1,16459151
0,22.0,Myelodysplastic syndrome,6,16459176
1,22.0,Laboratory test abnormal,6,16459176
0,22.1,Febrile neutropenia,5,16459184
1,22.1,Septic shock,5,16459184
2,22.1,Colitis,5,16459184
0,22.0,Bladder cancer recurrent,3,16459211
0,22.0,Macular oedema,2,16459369
0,22.0,Death,5,16459498
0,22.0,Death,5,16459503
0,22.0,Ovarian cancer recurrent,6,16459523
0,22.0,Renal impairment,2,16459527
0,22.0,Death,5,16459697
0,22.0,Death,5,16459732
0,22.0,Device expulsion,6,16459885
1,22.0,Wound dehiscence,3,16459885
0,22.0,Alanine aminotransferase increased,1,16459886
1,22.0,Blood bilirubin increased,1,16459886
2,22.0,Aspartate aminotransferase increased,1,16459886
3,22.0,Gamma-glutamyltransferase increased,1,16459886
0,22.0,Interstitial lung disease,3,16459888
0,22.0,Anaemia,6,16459891
1,22.0,Red blood cell count decreased,6,16459891
2,22.0,Carbohydrate antigen 125 increased,3,16459891
3,22.0,Gait inability,1,16459891
4,22.0,Somnolence,1,16459891
0,22.0,Vision blurred,3,16459963
0,22.0,Influenza,6,16460024
1,22.0,Hypertension,1,16460024
2,22.0,Cardiac failure,1,16460024
0,22.0,Enterocutaneous fistula,6,16460031
1,22.0,Embolism,6,16460031
2,22.0,Drug hypersensitivity,2,16460031
3,22.0,Pruritus,2,16460031
4,22.0,Asthma,6,16460031
5,22.0,Dyspnoea,6,16460031
6,22.0,Wound infection,6,16460031
7,22.0,Neoplasm progression,6,16460031
0,22.0,Acute leukaemia,6,16460062
1,22.0,Second primary malignancy,6,16460062
0,22.0,Fungal infection,3,16460083
1,22.0,Diarrhoea,3,16460083
2,22.0,Decreased appetite,3,16460083
0,22.0,Drug ineffective,6,16460093
1,22.0,Nausea,3,16460093
2,22.0,Brain neoplasm malignant,3,16460093
3,22.0,Dysgeusia,3,16460093
0,22.0,Neutropenia,1,16460107
0,22.0,Amnesia,6,16460141
1,22.0,Alopecia,3,16460141
2,22.0,Hair disorder,3,16460141
3,22.0,Madarosis,3,16460141
4,22.0,Hair texture abnormal,3,16460141
5,22.0,Depression,6,16460141
6,22.0,Hair colour changes,3,16460141
7,22.0,Anxiety,6,16460141
0,22.0,Radiation pneumonitis,3,16460209
0,22.0,Hepatitis E,1,16460278
0,22.0,Deep vein thrombosis,6,16460293
1,22.0,Anaemia,6,16460293
2,22.0,Rash,6,16460293
3,22.0,Stomatitis,6,16460293
4,22.0,Dyspnoea,6,16460293
5,22.0,Therapy partial responder,6,16460293
6,22.0,Nasal septum perforation,6,16460293
7,22.0,Wheezing,6,16460293
8,22.0,Skin toxicity,6,16460293
9,22.0,Adenocarcinoma of colon,6,16460293
10,22.0,Neutropenia,6,16460293
0,22.0,Anaemia,6,16460341
1,22.0,Small intestinal haemorrhage,1,16460341
2,22.0,Renal impairment,6,16460341
3,22.0,Neutropenia,6,16460341
4,22.0,Bone marrow disorder,6,16460341
0,22.0,Osteonecrosis of jaw,1,16460361
1,22.0,Condition aggravated,6,16460361
2,22.0,Acute sinusitis,1,16460361
3,22.0,Chronic sinusitis,6,16460361
0,22.0,Acute abdomen,2,16460388
1,22.0,Gastrointestinal oedema,1,16460388
2,22.0,Pancreatitis acute,6,16460388
3,22.0,Hyperfibrinolysis,6,16460388
4,22.0,Hyperlipidaemia,6,16460388
5,22.0,Hypercoagulation,6,16460388
6,22.0,Blood triglycerides increased,1,16460388
7,22.0,Mesenteritis,1,16460388
8,22.0,Vascular insufficiency,6,16460388
0,22.0,Drug eruption,2,16460403
0,22.0,Cerebrovascular accident,6,16460414
1,22.0,Off label use,6,16460414
0,22.0,Tracheal obstruction,6,16460421
0,22.0,Fatigue,6,16460423
1,22.0,Urinary tract infection,6,16460423
2,22.0,Blood magnesium decreased,6,16460423
3,22.0,Body temperature increased,6,16460423
4,22.0,Weight decreased,6,16460423
5,22.0,Nausea,2,16460423
6,22.0,Blood potassium decreased,6,16460423
7,22.0,Diarrhoea,2,16460423
8,22.0,Blood pressure increased,1,16460423
9,22.0,Oral pain,6,16460423
0,22.1,Bone pain,6,16460485
1,22.1,Weight decreased,6,16460485
2,22.1,Alopecia,6,16460485
3,22.1,Asthma,6,16460485
0,22.0,Blood count abnormal,3,16460560
0,22.0,Type 1 diabetes mellitus,6,16460678
1,22.0,Diabetic ketoacidotic hyperglycaemic coma,6,16460678
0,22.0,Left ventricular dysfunction,1,16460733
1,22.0,Palpitations,1,16460733
2,22.0,Asphyxia,1,16460733
3,22.0,Palpitations,2,16460733
4,22.0,Chest discomfort,2,16460733
5,22.0,Dyspnoea,1,16460733
0,22.0,Colon cancer,6,16460771
0,22.0,Enterovesical fistula,6,16460776
1,22.0,BRCA1 gene mutation,6,16460776
0,22.0,Bedridden,3,16460783
1,22.0,Pain,3,16460783
2,22.0,Decreased appetite,3,16460783
3,22.0,Asthenia,3,16460783
4,22.0,Fatigue,3,16460783
5,22.0,Malignant neoplasm progression,3,16460783
6,22.0,Weight decreased,3,16460783
0,22.0,Chemotherapy,6,16460843
1,22.0,Pneumonia,1,16460843
0,22.0,Tachycardia,2,16460922
1,22.0,Anaemia,2,16460922
2,22.0,Leukocytosis,2,16460922
3,22.0,Product use in unapproved indication,6,16460922
4,22.0,Asthenia,2,16460922
5,22.0,Venous thrombosis,1,16460922
6,22.0,Sepsis,2,16460922
7,22.0,Atrial thrombosis,1,16460922
8,22.0,Pyrexia,2,16460922
9,22.0,Pulmonary embolism,1,16460922
10,22.0,Drug ineffective,2,16460922
11,22.0,Pneumonia,2,16460922
12,22.0,Thrombocytopenia,1,16460922
13,22.0,Hyponatraemia,2,16460922
14,22.0,Hypokalaemia,2,16460922
15,22.0,Tongue dry,2,16460922
16,22.0,C-reactive protein increased,2,16460922
0,22.0,Leukoencephalopathy,2,16460968
0,22.0,Neurotoxicity,2,16460969
0,22.0,Leukoencephalopathy,1,16460970
0,22.0,Leukoencephalopathy,1,16460973
0,22.0,Neutrophil count decreased,1,16460981
1,22.0,Fatigue,2,16460981
2,22.0,Neutrophil count decreased,6,16460981
0,22.0,Sinus arrest,1,16460982
1,22.0,Syncope,1,16460982
2,22.0,Sinus bradycardia,1,16460982
0,22.0,Vomiting,6,16460987
1,22.0,Neurotoxicity,6,16460987
2,22.0,Bone marrow failure,6,16460987
0,22.0,Cerebellar ataxia,1,16460991
1,22.0,Neurotoxicity,1,16460991
0,22.0,Leukoencephalopathy,1,16460998
0,22.0,Stress cardiomyopathy,2,16461000
0,22.0,Leukoencephalopathy,1,16461001
0,22.0,Upper respiratory tract infection,1,16461018
1,22.0,Throat tightness,1,16461018
2,22.0,Pleural disorder,4,16461018
3,22.0,Depression,3,16461018
4,22.0,Weight decreased,1,16461018
5,22.0,Fatigue,3,16461018
6,22.0,Neutrophil count decreased,6,16461018
7,22.0,Dyspnoea,1,16461018
8,22.0,Pleural effusion,1,16461018
9,22.0,Pleural effusion,1,16461018
10,22.0,Peripheral swelling,1,16461018
11,22.0,Pleural effusion,1,16461018
12,22.0,Back pain,1,16461018
0,22.0,Pain,2,16461026
1,22.0,Muscle rigidity,2,16461026
0,22.0,Liver disorder,6,16461056
0,22.0,Hypothyroidism,2,16461068
1,22.0,Skin laceration,6,16461068
2,22.0,Pyrexia,2,16461068
3,22.0,Sepsis,2,16461068
4,22.0,White blood cell count decreased,3,16461068
5,22.0,C-reactive protein increased,6,16461068
6,22.0,Neutrophil count decreased,3,16461068
0,22.0,Osteonecrosis of jaw,6,16461116
0,22.0,Restlessness,6,16461164
1,22.0,Discomfort,6,16461164
2,22.0,Neurotoxicity,3,16461164
3,22.0,Delirium,3,16461164
4,22.0,Dehydration,6,16461164
5,22.0,Confusional state,6,16461164
6,22.0,Myoclonus,3,16461164
7,22.0,Pain,2,16461164
8,22.0,Coagulopathy,1,16461164
9,22.0,Renal impairment,6,16461164
10,22.0,General physical health deterioration,6,16461164
11,22.0,Thrombosis,6,16461164
12,22.0,Muscle contractions involuntary,2,16461164
13,22.0,Malnutrition,6,16461164
14,22.0,Constipation,6,16461164
15,22.0,Death,5,16461164
16,22.0,Toxic encephalopathy,2,16461164
17,22.0,Renal infarct,6,16461164
18,22.0,Insomnia,6,16461164
19,22.0,Drug ineffective,6,16461164
0,22.0,Therapy cessation,6,16461173
0,22.0,Nausea,1,16461287
1,22.0,Aspartate aminotransferase increased,1,16461287
2,22.0,Alanine aminotransferase increased,1,16461287
0,22.0,Somnolence,2,16461297
1,22.0,Hyperglycaemia,4,16461297
2,22.0,Diabetic ketoacidosis,2,16461297
3,22.0,Asthenia,2,16461297
0,22.0,Hypothyroidism,1,16461374
1,22.0,Hypertension,1,16461374
2,22.0,Thrombotic microangiopathy,1,16461374
3,22.0,Pericardial effusion,3,16461374
0,22.0,Malignant neoplasm progression,5,16461406
1,22.0,Inappropriate schedule of product administration,6,16461406
0,22.0,Death,5,16461409
0,22.0,Death,5,16461410
0,22.0,Death,5,16461419
0,22.0,Anti-neutrophil cytoplasmic antibody positive vasculitis,6,16461423
0,22.0,Ocular vascular disorder,6,16461526
1,22.0,Retinopathy,6,16461526
2,22.0,Blindness,1,16461526
0,22.0,Ileus,6,16461533
0,22.0,Hepatic cyst,6,16461538
1,22.0,Diverticulum gastric,6,16461538
2,22.0,Insomnia,6,16461538
3,22.0,Thrombocytopenia,1,16461538
4,22.0,Anaemia,6,16461538
5,22.0,Blood calcium decreased,6,16461538
6,22.0,Rash,1,16461538
7,22.0,Nausea,1,16461538
8,22.0,Blood potassium decreased,6,16461538
9,22.0,Vomiting,1,16461538
10,22.0,Hepatic steatosis,6,16461538
11,22.0,Mood altered,6,16461538
12,22.0,Blood magnesium decreased,6,16461538
13,22.0,Gastrooesophageal reflux disease,6,16461538
14,22.0,Escherichia bacteraemia,6,16461538
15,22.0,Cough,6,16461538
16,22.0,Skin reaction,6,16461538
17,22.0,Angioedema,6,16461538
18,22.0,Abdominal pain,6,16461538
19,22.0,Decreased appetite,6,16461538
20,22.0,Asthenia,6,16461538
21,22.0,Fatigue,6,16461538
22,22.0,Diarrhoea,6,16461538
23,22.0,Pyrexia,6,16461538
0,22.0,Inappropriate schedule of product administration,6,16461544
1,22.0,Malignant neoplasm progression,6,16461544
0,22.0,Syncope,1,16461545
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16461589
1,22.0,Neutropenia,6,16461589
0,22.0,Dementia Alzheimer^s type,4,16461594
1,22.0,Encephalitis,4,16461594
0,22.0,Device related infection,1,16461604
1,22.0,Gastric infection,3,16461604
2,22.0,Device related infection,6,16461604
3,22.0,Neutropenia,6,16461604
0,22.0,Death,5,16461615
0,22.1,Pemphigoid,2,16461621
0,22.0,Dyspnoea,6,16461625
1,22.0,Fall,6,16461625
2,22.0,Rib fracture,6,16461625
3,22.0,Back pain,6,16461625
0,22.0,Progressive multifocal leukoencephalopathy,6,16461626
1,22.0,Seizure,6,16461626
2,22.0,Encephalitis,6,16461626
3,22.0,Loss of consciousness,6,16461626
4,22.0,Multiple sclerosis,6,16461626
0,22.0,Headache,4,16461645
1,22.0,Pain in extremity,4,16461645
2,22.0,Dizziness,4,16461645
0,22.0,Hyperbilirubinaemia,1,16461647
0,22.0,Confusional state,1,16461815
1,22.0,Hypoglycaemia,1,16461815
2,22.0,Hypercalcaemia,6,16461815
3,22.0,Type 2 diabetes mellitus,6,16461815
4,22.0,Vena cava thrombosis,6,16461815
5,22.0,Pulmonary microemboli,6,16461815
6,22.0,Asthenia,1,16461815
0,22.1,Inappropriate antidiuretic hormone secretion,6,16461826
1,22.1,Hyponatraemia,1,16461826
0,22.0,Gastrointestinal ischaemia,6,16461856
1,22.0,Gastrointestinal necrosis,6,16461856
0,22.0,Acute kidney injury,1,16461858
0,22.0,Myelodysplastic syndrome,3,16461902
1,22.0,Thrombocytopenia,3,16461902
2,22.0,Neutropenia,3,16461902
0,22.1,Taste disorder,2,16461942
1,22.1,Pulmonary embolism,2,16461942
2,22.1,Off label use,6,16461942
3,22.1,Interstitial lung disease,2,16461942
4,22.1,Pleural effusion,6,16461942
5,22.1,Blood creatinine increased,2,16461942
0,22.0,Gastrointestinal perforation,6,16461954
0,22.0,Ascites,6,16461962
1,22.0,Drug ineffective,6,16461962
2,22.0,Abdominal distension,6,16461962
3,22.0,Organ failure,6,16461962
0,22.0,Drug intolerance,6,16461963
0,22.0,Hypotension,1,16462021
1,22.0,Prothrombin time prolonged,1,16462021
2,22.0,Vertigo,1,16462021
3,22.0,Vertigo,1,16462021
4,22.0,Loss of consciousness,1,16462021
0,22.0,Intracardiac thrombus,6,16462039
1,22.0,Ventricular tachycardia,6,16462039
2,22.0,Chest pain,6,16462039
3,22.0,Disease recurrence,6,16462039
4,22.0,Haemorrhagic infarction,6,16462039
5,22.0,Drug ineffective,6,16462039
6,22.0,Vascular stent thrombosis,6,16462039
7,22.0,Acute myocardial infarction,6,16462039
0,22.0,Hypergammaglobulinaemia benign monoclonal,6,16462042
0,22.0,Bone marrow failure,6,16462046
0,22.0,Eosinophilic fasciitis,2,16462064
0,22.0,Productive cough,6,16462080
1,22.0,Leukopenia,6,16462080
2,22.0,Thrombocytopenia,6,16462080
3,22.0,Diarrhoea,6,16462080
4,22.0,Pyrexia,6,16462080
5,22.0,Gastritis,6,16462080
0,22.0,Pelvic neoplasm,6,16462081
1,22.0,Hepatic lesion,6,16462081
0,22.1,Cystitis,1,16462118
1,22.1,Dehydration,1,16462118
2,22.1,Hyponatraemia,1,16462118
3,22.1,Influenza,1,16462118
4,22.1,Diarrhoea,1,16462118
0,22.0,Disorientation,6,16462161
1,22.0,Pelvic pain,6,16462161
2,22.0,Blood creatinine increased,6,16462161
3,22.0,Headache,6,16462161
4,22.0,Hemiparesis,6,16462161
5,22.0,Balance disorder,6,16462161
6,22.0,Granulocytosis,6,16462161
7,22.0,Dizziness,6,16462161
8,22.0,Leukocytosis,6,16462161
9,22.0,Peripheral sensory neuropathy,6,16462161
10,22.0,Vertigo,6,16462161
0,22.0,Pigmentation disorder,3,16462176
1,22.0,Lacrimation increased,3,16462176
2,22.0,Rhinitis,3,16462176
3,22.0,Sensory disturbance,6,16462176
4,22.0,Onychoclasis,3,16462176
5,22.0,Hypoaesthesia,6,16462176
6,22.0,Polyneuropathy,6,16462176
7,22.0,Dry skin,3,16462176
8,22.0,Madarosis,3,16462176
0,22.0,Cardiac failure,6,16462185
1,22.0,Metastases to liver,6,16462185
2,22.0,Hepatic cirrhosis,6,16462185
3,22.0,Cough,6,16462185
4,22.0,Breast cancer metastatic,6,16462185
5,22.0,Malignant neoplasm progression,6,16462185
6,22.0,Hepatic function abnormal,6,16462185
7,22.0,Dyspnoea,6,16462185
8,22.0,Product use in unapproved indication,6,16462185
9,22.0,Orthopnoea,6,16462185
0,22.0,Encephalitis autoimmune,4,16462187
1,22.0,Influenza,1,16462187
0,22.0,Musculoskeletal stiffness,1,16462222
1,22.0,Meniere^s disease,1,16462222
2,22.0,Decreased appetite,1,16462222
3,22.0,Tension headache,1,16462222
4,22.0,Weight decreased,1,16462222
5,22.0,Fatigue,6,16462222
0,22.0,Death,5,16462280
0,22.0,Off label use,3,16462295
1,22.0,Nephropathy toxic,6,16462295
2,22.0,Ascites,6,16462295
3,22.0,Pleural effusion,6,16462295
0,22.0,Death,5,16462328
0,22.0,Renal atrophy,6,16462362
1,22.0,Rash,6,16462362
2,22.0,Product dose omission,6,16462362
0,22.1,Neoplasm progression,6,16462374
1,22.1,Anxiety,6,16462374
2,22.1,Deafness,3,16462374
0,22.1,Malaise,2,16462388
1,22.1,Neoplasm progression,5,16462388
0,22.0,Full blood count decreased,6,16462393
1,22.0,Neoplasm progression,3,16462393
2,22.0,Peripheral swelling,2,16462393
3,22.0,Hypoaesthesia,2,16462393
4,22.0,Gallbladder disorder,6,16462393
5,22.0,Neutropenia,6,16462393
6,22.0,Ascites,6,16462393
7,22.0,Abdominal pain,6,16462393
8,22.0,Paraesthesia,2,16462393
9,22.0,Lithiasis,6,16462393
10,22.0,Nausea,6,16462393
11,22.0,Malaise,3,16462393
0,22.0,Crystal arthropathy,2,16462394
0,22.1,Headache,1,16462442
1,22.1,Feeling hot,1,16462442
0,22.0,Lower respiratory tract infection,1,16462446
0,22.0,Hypertransaminasaemia,2,16462456
1,22.0,Neutropenia,2,16462456
0,22.1,Death,5,16462464
1,22.1,Limb injury,3,16462464
2,22.1,Fall,3,16462464
3,22.1,Rib fracture,3,16462464
0,22.0,Pyrexia,1,16462483
1,22.0,Oesophageal perforation,1,16462483
2,22.0,Abdominal pain upper,1,16462483
3,22.0,Pleural effusion,1,16462483
4,22.0,Abscess,1,16462483
5,22.0,Inflammation,1,16462483
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16462503
1,22.0,Fracture,6,16462503
2,22.0,Fall,6,16462503
0,22.0,Death,5,16462512
0,22.0,Neutropenia,6,16462513
0,22.0,Immune-mediated adverse reaction,6,16462566
0,22.0,Nasopharyngitis,6,16462601
1,22.0,Oropharyngeal pain,6,16462601
2,22.0,Cystitis,6,16462601
3,22.0,Withdrawal syndrome,3,16462601
4,22.0,Acne,6,16462601
5,22.0,Stomatitis,6,16462601
6,22.0,Oral herpes,6,16462601
7,22.0,Pain,6,16462601
8,22.0,Diarrhoea,6,16462601
9,22.0,Malignant neoplasm progression,3,16462601
10,22.0,Skin disorder,6,16462601
11,22.0,Blood pressure increased,6,16462601
12,22.0,Injury,6,16462601
13,22.0,Neoplasm progression,6,16462601
14,22.0,Visual impairment,2,16462601
15,22.0,Rhinorrhoea,6,16462601
16,22.0,Hair disorder,3,16462601
0,22.0,Andropause,3,16462609
1,22.0,Memory impairment,3,16462609
2,22.0,Asphyxia,3,16462609
3,22.0,Hyporesponsive to stimuli,3,16462609
4,22.0,Hot flush,6,16462609
5,22.0,Libido decreased,3,16462609
0,22.0,Injection site extravasation,6,16462685
0,22.0,Chest pain,2,16462686
0,22.0,Erythema,1,16462687
1,22.0,Dyspnoea,1,16462687
2,22.0,Anxiety,1,16462687
3,22.0,Chest discomfort,1,16462687
0,22.0,Pancytopenia,1,16462692
1,22.0,Renal failure,1,16462692
0,22.0,Cytoreductive surgery,6,16462735
0,22.0,Cardiac arrest,5,16462763
0,22.0,Erythema,1,16462765
1,22.0,Hypotension,1,16462765
2,22.0,Nausea,1,16462765
3,22.0,Abdominal pain upper,1,16462765
4,22.0,Hypersensitivity,1,16462765
0,22.0,Blood pressure diastolic increased,1,16462769
1,22.0,Panic attack,1,16462769
0,22.0,Anaemia,2,16462770
1,22.0,Hypertransaminasaemia,2,16462770
0,22.0,Rash,6,16462813
1,22.0,Skin discolouration,6,16462813
0,22.1,Dry mouth,3,16462825
1,22.1,Constipation,3,16462825
2,22.1,Diarrhoea,3,16462825
3,22.1,Paraesthesia oral,2,16462825
4,22.1,Hair colour changes,3,16462825
5,22.1,Blood pressure decreased,1,16462825
6,22.1,Neuropathy peripheral,3,16462825
7,22.1,Nail disorder,3,16462825
8,22.1,Dry skin,3,16462825
9,22.1,Hyperhidrosis,3,16462825
10,22.1,Alopecia,6,16462825
11,22.1,Fatigue,3,16462825
12,22.1,Tongue coated,2,16462825
13,22.1,Hair texture abnormal,3,16462825
14,22.1,Onychoclasis,6,16462825
15,22.1,Insomnia,3,16462825
16,22.1,Dry eye,3,16462825
17,22.1,Musculoskeletal pain,3,16462825
18,22.1,Emotional distress,6,16462825
19,22.1,Mucosal dryness,3,16462825
20,22.1,Product odour abnormal,6,16462825
0,22.0,Myasthenia gravis,5,16462879
1,22.0,Pneumonia aspiration,5,16462879
2,22.0,Septic shock,5,16462879
3,22.0,Encephalitis,5,16462879
4,22.0,Acute respiratory distress syndrome,5,16462879
0,22.0,Decreased appetite,6,16462974
1,22.0,Neuropathy peripheral,6,16462974
2,22.0,Malignant neoplasm progression,5,16462974
0,22.0,Fatigue,6,16463017
1,22.0,Blood bilirubin increased,6,16463017
2,22.0,Rash,6,16463017
0,22.0,Lung disorder,3,16463020
0,22.0,Interstitial lung disease,5,16463030
0,22.0,Erythema multiforme,2,16463068
0,22.0,Rash,6,16463104
1,22.0,Pruritus,3,16463104
2,22.0,Malignant neoplasm progression,6,16463104
3,22.0,Drug resistance,6,16463104
0,22.0,Gastroenteritis norovirus,5,16463150
0,22.0,Neoplasm progression,6,16463154
1,22.0,White blood cell count decreased,6,16463154
0,22.0,Neoplasm progression,6,16463168
0,22.1,White blood cell count decreased,6,16463169
0,22.0,Tumour marker increased,6,16463177
0,22.0,Fatigue,6,16463180
0,22.0,Intentional product use issue,6,16463200
1,22.0,Dysstasia,6,16463200
2,22.0,Movement disorder,6,16463200
3,22.0,Sinusitis,6,16463200
4,22.0,Muscle tightness,6,16463200
5,22.0,Arthropathy,6,16463200
6,22.0,Muscle disorder,6,16463200
7,22.0,Asthenia,6,16463200
8,22.0,Fatigue,6,16463200
9,22.0,Muscular weakness,6,16463200
10,22.0,Loss of personal independence in daily activities,6,16463200
11,22.0,Stomatitis,6,16463200
12,22.0,Neutropenia,1,16463200
0,22.0,Product use in unapproved indication,6,16463211
1,22.0,Off label use,6,16463211
2,22.0,Neoplasm progression,6,16463211
0,22.1,Alopecia,2,16463235
1,22.1,Sinusitis,3,16463235
2,22.1,Upper respiratory tract infection,3,16463235
3,22.1,Hypersensitivity,6,16463235
4,22.1,Fatigue,3,16463235
5,22.1,Malignant neoplasm progression,6,16463235
6,22.1,Secretion discharge,6,16463235
7,22.1,Nausea,3,16463235
8,22.1,Cardiac flutter,6,16463235
9,22.1,Gastrooesophageal reflux disease,6,16463235
10,22.1,Dysphonia,6,16463235
11,22.1,Heart rate increased,6,16463235
12,22.1,Headache,1,16463235
13,22.1,Ovarian cancer metastatic,6,16463235
14,22.1,Platelet count decreased,3,16463235
15,22.1,Tongue discomfort,6,16463235
16,22.1,Abdominal discomfort,6,16463235
17,22.1,Oropharyngeal discomfort,6,16463235
18,22.1,Underdose,6,16463235
0,22.0,Cardiac disorder,6,16463253
0,22.1,Neutropenic sepsis,1,16463259
1,22.1,Autoimmune hepatitis,1,16463259
0,22.0,Alopecia,6,16463318
1,22.0,Tooth loss,6,16463318
2,22.0,Tooth disorder,6,16463318
3,22.0,Psoriasis,6,16463318
0,22.0,Tremor,6,16463324
1,22.0,Asthenia,6,16463324
0,22.1,Cough,6,16463332
1,22.1,Abdominal pain upper,1,16463332
2,22.1,Diarrhoea,1,16463332
0,22.0,Neoplasm progression,6,16463344
0,22.0,Feeling abnormal,6,16463364
0,22.0,Oropharyngeal discomfort,1,16463373
1,22.0,Adverse reaction,3,16463373
2,22.0,Pain,1,16463373
3,22.0,Abdominal pain upper,1,16463373
4,22.0,White blood cell disorder,3,16463373
5,22.0,Feeling abnormal,3,16463373
6,22.0,Feeling cold,3,16463373
7,22.0,Headache,1,16463373
0,22.0,Febrile neutropenia,1,16463524
1,22.0,Sepsis,1,16463524
0,22.0,Death,5,16463535
0,22.0,White blood cell count decreased,6,16463539
1,22.0,Bone marrow failure,6,16463539
2,22.0,Fatigue,6,16463539
3,22.0,Platelet count decreased,6,16463539
4,22.0,Dyspnoea,6,16463539
5,22.0,Cardiac disorder,6,16463539
6,22.0,Sleep disorder,6,16463539
7,22.0,Red blood cell count decreased,6,16463539
8,22.0,Chest discomfort,6,16463539
0,22.0,Immune-mediated adverse reaction,3,16463560
1,22.0,Tubulointerstitial nephritis,3,16463560
0,22.1,Pain in extremity,1,16463578
1,22.1,Blood magnesium decreased,6,16463578
2,22.1,Myalgia,3,16463578
3,22.1,Vomiting,1,16463578
4,22.1,Palpitations,2,16463578
5,22.1,Insomnia,3,16463578
6,22.1,Alopecia,3,16463578
7,22.1,Dyspnoea exertional,1,16463578
8,22.1,Peripheral swelling,1,16463578
9,22.1,Back pain,3,16463578
10,22.1,Headache,2,16463578
11,22.1,Pyrexia,1,16463578
12,22.1,Pyrexia,1,16463578
13,22.1,Haemoglobin decreased,6,16463578
14,22.1,Arthralgia,3,16463578
15,22.1,Hot flush,3,16463578
16,22.1,Oedema peripheral,3,16463578
17,22.1,Hypophosphataemia,1,16463578
18,22.1,Fatigue,3,16463578
19,22.1,Nausea,3,16463578
20,22.1,Skin reaction,6,16463578
21,22.1,Chills,1,16463578
22,22.1,Monocyte count decreased,6,16463578
23,22.1,Blood phosphorus decreased,6,16463578
24,22.1,Anxiety,3,16463578
25,22.1,Platelet count decreased,1,16463578
26,22.1,Adjusted calcium decreased,6,16463578
27,22.1,Lymphocyte count decreased,6,16463578
28,22.1,Abdominal pain,3,16463578
29,22.1,Erythema,1,16463578
30,22.1,Neutropenia,1,16463578
31,22.1,Alanine aminotransferase increased,6,16463578
32,22.1,Blood alkaline phosphatase increased,6,16463578
33,22.1,Gastrooesophageal reflux disease,3,16463578
34,22.1,Dizziness,3,16463578
35,22.1,Constipation,3,16463578
36,22.1,Haematocrit decreased,6,16463578
37,22.1,White blood cell count decreased,6,16463578
38,22.1,Pruritus,3,16463578
39,22.1,Diarrhoea,1,16463578
40,22.1,Urinary tract infection,1,16463578
0,22.0,Decreased appetite,,16463619
1,22.0,Rash,,16463619
2,22.0,Weight decreased,,16463619
0,22.0,Cholecystitis acute,1,16463665
0,22.0,Anaemia,6,16463679
1,22.0,Death,5,16463679
2,22.0,Red blood cell abnormality,6,16463679
3,22.0,Diverticulitis,6,16463679
0,22.0,Decreased appetite,3,16463680
1,22.0,Fatigue,3,16463680
2,22.0,Diarrhoea,3,16463680
3,22.0,Transfusion,3,16463680
4,22.0,Product dose omission,6,16463680
0,22.0,Death,5,16463723
0,22.0,Oedema peripheral,3,16463748
1,22.0,Cytopenia,6,16463748
2,22.0,Fatigue,3,16463748
3,22.0,Death,5,16463748
0,22.0,No adverse event,1,16463768
0,22.0,Death,5,16463780
0,22.0,Product use in unapproved indication,6,16463783
1,22.0,Adverse drug reaction,6,16463783
0,22.0,Vaginal haemorrhage,5,16463786
1,22.0,Endometrial cancer,5,16463786
2,22.0,Product use in unapproved indication,6,16463786
0,22.0,Death,5,16463794
0,22.0,Ligament sprain,2,16463802
1,22.0,Disease progression,6,16463802
0,22.0,Balance disorder,,16463833
0,22.0,Dyspnoea,3,16463848
1,22.0,Drug ineffective,6,16463848
2,22.0,Fatigue,3,16463848
3,22.0,Pulmonary oedema,3,16463848
0,22.0,Haemorrhage,1,16463862
1,22.0,Activated partial thromboplastin time prolonged,1,16463862
2,22.0,Anti factor X activity increased,1,16463862
0,22.0,Hyperthermia,5,16463868
1,22.0,Febrile neutropenia,5,16463868
0,22.0,Osteonecrosis of jaw,3,16463873
0,22.0,Colitis,4,16463876
0,22.0,Rash,,16463996
1,22.0,Pruritus,,16463996
0,22.0,Necrotising colitis,,16464015
1,22.0,Cardiac arrest,,16464015
2,22.0,Septic shock,,16464015
3,22.0,Metabolic acidosis,,16464015
4,22.0,Syncope,,16464015
5,22.0,Hypotension,,16464015
0,22.0,Condition aggravated,6,16464023
1,22.0,Hypophagia,2,16464023
2,22.0,Dysgeusia,6,16464023
3,22.0,Femur fracture,6,16464023
0,22.0,Venoocclusive liver disease,3,16464028
0,22.1,Benign prostatic hyperplasia,3,16464032
1,22.1,Small intestinal obstruction,1,16464032
2,22.1,Pyrexia,1,16464032
3,22.1,Diarrhoea,3,16464032
4,22.1,Neutropenia,1,16464032
5,22.1,Orthostatic hypotension,3,16464032
6,22.1,Cholangitis acute,1,16464032
7,22.1,Stomatitis,1,16464032
8,22.1,Platelet count decreased,3,16464032
9,22.1,Obstruction gastric,1,16464032
10,22.1,Anaemia,3,16464032
11,22.1,Dermatitis allergic,1,16464032
12,22.1,Intestinal obstruction,1,16464032
0,22.0,Pruritus,,16464060
1,22.0,Abdominal pain upper,,16464060
2,22.0,Infusion related reaction,,16464060
0,22.0,Hot flush,,16464076
0,22.0,Neurotoxicity,6,16464082
1,22.0,Neutropenia,6,16464082
2,22.0,Disease progression,6,16464082
3,22.0,Haematotoxicity,6,16464082
0,22.0,Hyperkalaemia,1,16464093
1,22.0,Metabolic acidosis,1,16464093
2,22.0,Cardio-respiratory arrest,1,16464093
3,22.0,Acute kidney injury,1,16464093
0,22.0,Acute myeloid leukaemia,3,16464094
0,22.0,Death,,16464135
0,22.0,Paraesthesia,,16464146
1,22.0,Hypoaesthesia,,16464146
0,22.0,Abdominal distension,,16464177
0,22.0,Haemorrhagic infarction,3,16464300
1,22.0,Ventricular tachycardia,3,16464300
2,22.0,Chest pain,3,16464300
3,22.0,Acute myocardial infarction,3,16464300
4,22.0,Vascular stent thrombosis,3,16464300
5,22.0,Intracardiac thrombus,3,16464300
6,22.0,Drug ineffective,3,16464300
0,22.0,Diarrhoea,,16464361
1,22.0,Blood sodium decreased,,16464361
0,22.0,Pneumonia,1,16464378
0,22.1,Rib fracture,6,16464401
1,22.1,Blood pressure increased,1,16464401
2,22.1,Weight decreased,1,16464401
3,22.1,Pneumothorax,6,16464401
4,22.1,Pneumonia,1,16464401
5,22.1,Infection,6,16464401
6,22.1,Lip swelling,6,16464401
7,22.1,Fatigue,2,16464401
8,22.1,Decreased appetite,1,16464401
9,22.1,Fall,6,16464401
0,22.0,Rhabdomyolysis,6,16464460
1,22.0,Aspartate aminotransferase increased,6,16464460
2,22.0,Alanine aminotransferase increased,6,16464460
3,22.0,Fall,6,16464460
4,22.0,Protein urine,2,16464460
5,22.0,Hyperthyroidism,6,16464460
6,22.0,Hypothyroidism,6,16464460
7,22.0,Blood creatine phosphokinase increased,6,16464460
0,22.0,Throat irritation,6,16464473
1,22.0,Dyspnoea,6,16464473
2,22.0,Stomatitis,6,16464473
3,22.0,Somnolence,6,16464473
4,22.0,Pulmonary oedema,6,16464473
5,22.0,Cough,6,16464473
6,22.0,Vomiting,6,16464473
0,22.0,Pneumonitis,6,16464556
1,22.0,Vomiting,6,16464556
2,22.0,Diarrhoea,6,16464556
0,22.0,Onychoclasis,3,16464588
1,22.0,Hypoaesthesia,6,16464588
2,22.0,Polyneuropathy,6,16464588
3,22.0,Madarosis,3,16464588
4,22.0,Dry skin,3,16464588
5,22.0,Lacrimation increased,3,16464588
6,22.0,Pigmentation disorder,3,16464588
7,22.0,Sensory disturbance,6,16464588
8,22.0,Rhinitis,3,16464588
0,22.0,Peripheral swelling,6,16464618
1,22.0,Rash,6,16464618
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16464618
0,22.0,Diverticulitis,1,16464636
0,22.0,Product use in unapproved indication,6,16464708
1,22.0,Rash,6,16464708
2,22.0,Arthralgia,6,16464708
0,22.0,Terminal state,3,16464721
0,22.0,Small intestinal perforation,5,16464758
1,22.0,Gastrointestinal haemorrhage,6,16464758
2,22.0,Sepsis,6,16464758
3,22.0,Pancreatic enzymes increased,6,16464758
0,22.0,Death,5,16464817
1,22.0,Haemoglobin decreased,6,16464817
0,22.0,Endocarditis,6,16464872
0,22.0,Death,5,16464882
0,22.0,Rash maculo-papular,1,16464884
0,22.1,Thyroid cancer stage IV,5,16464927
1,22.1,Diarrhoea,1,16464927
2,22.1,Deep vein thrombosis,1,16464927
3,22.1,Rib fracture,4,16464927
4,22.1,Yellow skin,6,16464927
5,22.1,Vomiting,6,16464927
6,22.1,Pain,6,16464927
7,22.1,Product use in unapproved indication,6,16464927
8,22.1,Pulmonary embolism,1,16464927
9,22.1,Metastases to bone,6,16464927
10,22.1,Nausea,6,16464927
0,22.0,Anaemia,3,16464987
1,22.0,Urinary tract infection,2,16464987
0,22.0,Decreased appetite,,16465014
1,22.0,Skin disorder,,16465014
2,22.0,Weight decreased,,16465014
3,22.0,Transaminases increased,,16465014
4,22.0,Cachexia,,16465014
5,22.0,Nausea,,16465014
0,22.0,Off label use,,16465015
1,22.0,Hospitalisation,6,16465015
0,22.0,Diarrhoea,3,16465060
1,22.0,Febrile neutropenia,1,16465060
2,22.0,Hyperthermia,3,16465060
3,22.0,Dehydration,1,16465060
0,22.0,Posterior reversible encephalopathy syndrome,3,16465070
1,22.0,Interstitial lung disease,1,16465070
0,22.0,Nausea,6,16465114
1,22.0,Anaemia,6,16465114
2,22.0,Metastases to bone,6,16465114
3,22.0,Asthenia,6,16465114
0,22.0,Drug resistance,6,16465119
1,22.0,Malignant neoplasm progression,6,16465119
0,22.0,Lung disorder,2,16465120
1,22.0,Bone marrow failure,1,16465120
2,22.0,Interstitial lung disease,6,16465120
3,22.0,Pneumonia,6,16465120
0,22.1,Fistula,1,16465130
1,22.1,Anxiety,1,16465130
2,22.1,General physical health deterioration,3,16465130
3,22.1,Vomiting,3,16465130
4,22.1,Oedema peripheral,3,16465130
5,22.1,Thoracic vertebral fracture,3,16465130
6,22.1,Diarrhoea,3,16465130
7,22.1,Abdominal distension,1,16465130
8,22.1,Hypokalaemia,3,16465130
9,22.1,Dyspnoea,1,16465130
10,22.1,Weight decreased,1,16465130
11,22.1,Off label use,6,16465130
12,22.1,Headache,3,16465130
13,22.1,General physical health deterioration,1,16465130
0,22.0,Platelet count decreased,6,16465223
1,22.0,Metastatic neoplasm,6,16465223
0,22.1,Diarrhoea,1,16465247
1,22.1,Congestive cardiomyopathy,3,16465247
2,22.1,Electrocardiogram QT prolonged,2,16465247
3,22.1,Stomatitis,1,16465247
4,22.1,Venous thrombosis limb,3,16465247
5,22.1,Weight decreased,2,16465247
0,22.0,Haemoptysis,6,16465264
1,22.0,Malignant neoplasm progression,5,16465264
0,22.0,Tumour lysis syndrome,5,16465267
0,22.0,Aphonia,6,16465287
1,22.0,Intentional product misuse,6,16465287
2,22.0,Feeling abnormal,6,16465287
0,22.0,Nausea,4,16465319
1,22.0,Fatigue,2,16465319
2,22.0,Anaemia,1,16465319
3,22.0,Diarrhoea,4,16465319
4,22.0,Lethargy,2,16465319
5,22.0,Off label use,6,16465319
6,22.0,Product use in unapproved indication,6,16465319
7,22.0,Deep vein thrombosis,6,16465319
8,22.0,White blood cell count decreased,6,16465319
9,22.0,Oropharyngeal pain,1,16465319
10,22.0,Prostatic specific antigen increased,3,16465319
11,22.0,Vomiting,4,16465319
0,22.0,Nausea,1,16465335
1,22.0,Headache,1,16465335
2,22.0,Tremor,1,16465335
3,22.0,Dizziness,1,16465335
4,22.0,Diarrhoea,1,16465335
0,22.0,Neutropenia,6,16465340
1,22.0,Leukopenia,6,16465340
0,22.0,Death,5,16465361
0,22.1,Gastrointestinal necrosis,5,16465363
1,22.1,Neutropenia,5,16465363
0,22.1,Pseudocirrhosis,5,16465378
0,22.0,Death,5,16465411
1,22.0,Gastrointestinal haemorrhage,6,16465411
0,22.0,Malignant neoplasm progression,5,16465436
0,22.0,Hypertension,1,16465437
1,22.0,Hypokalaemia,3,16465437
2,22.0,Leukocyturia,3,16465437
3,22.0,Fatigue,3,16465437
4,22.0,Blood urine present,3,16465437
0,22.0,Anaemia,3,16465446
1,22.0,Infection,3,16465446
2,22.0,Polyneuropathy,3,16465446
3,22.0,Pyrexia,1,16465446
4,22.0,Pleural effusion,6,16465446
5,22.0,Leukopenia,1,16465446
6,22.0,Myocardial infarction,5,16465446
7,22.0,Neutropenia,1,16465446
0,22.0,Aphthous ulcer,6,16465448
1,22.0,Erythema,6,16465448
2,22.0,Death,5,16465448
3,22.0,Off label use,5,16465448
4,22.0,Leukopenia,6,16465448
5,22.0,Dysphagia,6,16465448
6,22.0,Throat irritation,6,16465448
7,22.0,Product use in unapproved indication,5,16465448
0,22.0,Dyspnoea,3,16465462
1,22.0,Nail infection,3,16465462
0,22.1,Drug ineffective,2,16465573
1,22.1,Anxiety,6,16465573
2,22.1,Delirium,6,16465573
0,22.0,Anaemia,3,16465583
1,22.0,Lung infection,1,16465583
0,22.1,Arthralgia,1,16465663
0,22.0,Electrocardiogram QT prolonged,6,16465664
1,22.0,Neutrophil count decreased,6,16465664
0,22.0,Pituitary cancer metastatic,6,16465670
1,22.0,Malignant neoplasm progression,6,16465670
2,22.0,Drug ineffective,6,16465670
0,22.0,Death,5,16465672
1,22.0,Inappropriate schedule of product administration,6,16465672
0,22.0,Pneumonitis,2,16465693
0,22.0,Interstitial lung disease,3,16465699
0,22.0,Death,5,16465705
0,22.0,Seizure,1,16465732
1,22.0,Colitis microscopic,1,16465732
0,22.0,Alopecia,3,16465738
1,22.0,Hair texture abnormal,3,16465738
2,22.0,Hair colour changes,3,16465738
3,22.0,Hair disorder,3,16465738
0,22.0,Dyspnoea,1,16465760
1,22.0,Pruritus,1,16465760
2,22.0,Chest discomfort,1,16465760
3,22.0,Flushing,1,16465760
4,22.0,Abdominal pain,1,16465760
5,22.0,Dizziness,1,16465760
0,22.1,Radiation pneumonitis,2,16465783
0,22.0,Rash,2,16465791
1,22.0,Pyrexia,2,16465791
2,22.0,Liver disorder,2,16465791
3,22.0,Decreased appetite,1,16465791
0,22.0,Biliary dilatation,6,16465801
1,22.0,Jaundice,3,16465801
2,22.0,Cholestasis,2,16465801
3,22.0,Ascites,6,16465801
0,22.0,Staphylococcal infection,6,16465827
1,22.0,Malaise,6,16465827
0,22.0,Malignant neoplasm progression,6,16465838
1,22.0,Tumour pseudoprogression,6,16465838
0,22.0,Product use in unapproved indication,6,16465878
1,22.0,Rash,3,16465878
0,22.0,Off label use,6,16465904
1,22.0,Polyuria,1,16465904
2,22.0,Immune-mediated adverse reaction,1,16465904
3,22.0,Incorrect dose administered,6,16465904
4,22.0,Pancytopenia,3,16465904
5,22.0,Urinary tract infection,1,16465904
6,22.0,Anaemia,1,16465904
7,22.0,Thrombocytopenia,1,16465904
8,22.0,Asthenia,1,16465904
9,22.0,Infection,1,16465904
10,22.0,Chills,1,16465904
11,22.0,Drug diversion,6,16465904
12,22.0,Decreased appetite,1,16465904
0,22.0,Intentional product use issue,6,16465925
1,22.0,Deep vein thrombosis,2,16465925
0,22.0,Death,5,16465934
0,22.0,Death,5,16465935
0,22.0,Death,5,16465939
0,22.0,Death,5,16465946
0,22.0,Death,5,16465948
0,22.0,Death,5,16465952
0,22.0,Death,5,16465956
0,22.0,Death,5,16465962
0,22.0,Death,5,16465963
0,22.0,Death,5,16465973
1,22.0,Encephalopathy,1,16465973
2,22.0,Therapy partial responder,3,16465973
3,22.0,Encephalitis,1,16465973
4,22.0,Product use in unapproved indication,6,16465973
5,22.0,Immune-mediated adverse reaction,3,16465973
6,22.0,Leukocytosis,3,16465973
0,22.0,Mucosal dryness,1,16466229
1,22.0,Staphylococcal skin infection,1,16466229
2,22.0,Respiratory tract infection,1,16466229
3,22.0,Anaemia,1,16466229
0,22.0,Ascites,6,16466230
1,22.0,Abdominal pain,6,16466230
2,22.0,Jaundice,6,16466230
0,22.0,Fall,6,16466252
0,22.0,Renal failure,6,16466279
1,22.0,Diabetic nephropathy,6,16466279
2,22.0,Cerebral atrophy,6,16466279
3,22.0,Type 2 diabetes mellitus,6,16466279
4,22.0,Cerebral infarction,6,16466279
5,22.0,Cerebral arteriosclerosis,6,16466279
6,22.0,Hypertension,6,16466279
7,22.0,Confusional state,6,16466279
8,22.0,Shock,6,16466279
9,22.0,Metabolic acidosis,6,16466279
10,22.0,Syncope,1,16466279
11,22.0,Nausea,6,16466279
12,22.0,Decreased appetite,6,16466279
13,22.0,Vomiting,6,16466279
0,22.0,Brain neoplasm malignant,6,16466303
0,22.0,Diarrhoea,6,16466319
1,22.0,Respiratory failure,5,16466319
0,22.0,Dyspnoea,6,16466321
1,22.0,Sepsis,6,16466321
2,22.0,Malignant neoplasm progression,6,16466321
0,22.0,Cardiotoxicity,6,16466322
1,22.0,Bone marrow failure,1,16466322
0,22.0,Immunodeficiency,6,16466334
1,22.0,Lung infection,5,16466334
0,22.0,Seizure,1,16466343
0,22.0,Death,5,16466355
0,22.0,Colitis,5,16466421
1,22.0,Agranulocytosis,5,16466421
2,22.0,Drug interaction,5,16466421
3,22.0,Large intestine perforation,5,16466421
0,22.0,Liver injury,2,16466438
0,22.0,Erythema,1,16466440
1,22.0,Feeling hot,1,16466440
2,22.0,Back pain,1,16466440
0,22.0,Pneumonia,5,16466445
1,22.0,Off label use,6,16466445
0,22.0,Surgery,3,16466469
0,22.0,Urinary tract infection,1,16466563
1,22.0,Hypokalaemia,1,16466563
0,22.0,Metastases to peritoneum,6,16466577
1,22.0,Blood calcium increased,6,16466577
2,22.0,Metastases to ovary,6,16466577
3,22.0,Malignant neoplasm progression,6,16466577
4,22.0,Metastases to the mediastinum,6,16466577
5,22.0,Breast cancer,6,16466577
0,22.0,Vomiting,3,16466578
1,22.0,Syncope,3,16466578
2,22.0,Dizziness,3,16466578
3,22.0,Malaise,3,16466578
4,22.0,Nausea,3,16466578
5,22.0,Asthenia,3,16466578
6,22.0,Palpitations,3,16466578
0,22.0,Abdominal pain upper,6,16466608
1,22.0,Bone marrow failure,6,16466608
2,22.0,Cholecystitis acute,1,16466608
3,22.0,Diarrhoea,6,16466608
0,22.0,Hot flush,3,16466725
0,22.1,Dermatitis acneiform,6,16466741
1,22.1,Pulmonary embolism,2,16466741
2,22.1,Paronychia,6,16466741
0,22.0,Dehydration,6,16466765
1,22.0,Nausea,6,16466765
2,22.0,Headache,2,16466765
3,22.0,Migraine,6,16466765
4,22.0,Hypophagia,6,16466765
0,22.0,Death,5,16466814
0,22.0,Off label use,6,16466824
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16466824
2,22.0,Intentional product use issue,6,16466824
3,22.0,Nausea,6,16466824
4,22.0,Bone marrow failure,6,16466824
5,22.0,Vomiting,6,16466824
0,22.0,Hypocalcaemia,1,16466925
0,22.0,Tooth extraction,6,16466936
0,22.0,Death,5,16467029
0,22.0,Encephalopathy,3,16467050
1,22.0,Abdominal pain,3,16467050
0,22.0,Polyneuropathy,2,16467132
0,22.0,Neurotoxicity,2,16467155
1,22.0,Malaise,2,16467155
2,22.0,Sleep disorder,2,16467155
3,22.0,Delirium,2,16467155
4,22.0,Drug ineffective,2,16467155
5,22.0,Muscle contractions involuntary,2,16467155
6,22.0,Myoclonus,2,16467155
7,22.0,Restlessness,2,16467155
8,22.0,Toxic encephalopathy,2,16467155
9,22.0,Constipation,2,16467155
10,22.0,Confusional state,2,16467155
11,22.0,Dehydration,2,16467155
0,22.0,Death,5,16467244
0,22.0,Metastases to lymph nodes,6,16467299
1,22.0,Metastases to liver,6,16467299
0,22.0,Fracture,6,16467301
0,22.0,Death,5,16467310
1,22.0,Intentional product use issue,6,16467310
0,22.0,Hypokalaemia,1,16467357
0,22.0,Transaminases increased,6,16467363
1,22.0,Immune-mediated pneumonitis,5,16467363
2,22.0,Myalgia,6,16467363
3,22.0,Cardiac disorder,5,16467363
4,22.0,Arthralgia,6,16467363
5,22.0,Diarrhoea,6,16467363
6,22.0,Skin disorder,6,16467363
7,22.0,Amylase increased,6,16467363
8,22.0,Endocrine disorder,6,16467363
9,22.0,Lipase increased,6,16467363
0,22.0,Acute respiratory failure,5,16467429
1,22.0,Haemoptysis,5,16467429
0,22.0,Acute kidney injury,1,16467433
1,22.0,Cardio-respiratory arrest,1,16467433
2,22.0,Metabolic acidosis,1,16467433
3,22.0,Hyperkalaemia,1,16467433
4,22.0,Drug interaction,6,16467433
0,22.0,Abdominal discomfort,6,16467446
0,22.0,Off label use,6,16467456
1,22.0,Febrile neutropenia,5,16467456
2,22.0,Pneumonia,5,16467456
0,22.1,Central nervous system lesion,1,16467471
0,22.1,Bedridden,6,16467528
0,22.1,Breast cancer,6,16467529
0,22.0,Diarrhoea,1,16467535
1,22.0,Pyrexia,1,16467535
2,22.0,Rash,1,16467535
3,22.0,Vomiting,1,16467535
0,22.0,Malignant neoplasm progression,6,16467601
0,22.0,Interstitial lung disease,2,16467653
0,22.0,Abdominal distension,3,16467673
1,22.0,Forced expiratory volume decreased,3,16467673
2,22.0,Humidity intolerance,3,16467673
3,22.0,Dehydration,3,16467673
4,22.0,Glossodynia,3,16467673
5,22.0,Hypoventilation,3,16467673
6,22.0,Seizure,3,16467673
7,22.0,Depressed mood,3,16467673
8,22.0,Asthma,3,16467673
9,22.0,Chest discomfort,3,16467673
10,22.0,Lacrimation increased,3,16467673
11,22.0,Respiratory rate increased,3,16467673
12,22.0,Wheezing,3,16467673
13,22.0,Chronic obstructive pulmonary disease,3,16467673
14,22.0,Gait disturbance,3,16467673
15,22.0,Obstructive airways disorder,3,16467673
16,22.0,Tongue haemorrhage,3,16467673
17,22.0,Blood pressure systolic increased,3,16467673
18,22.0,Heart rate increased,3,16467673
19,22.0,Inappropriate schedule of product administration,3,16467673
20,22.0,Dizziness,3,16467673
21,22.0,Abdominal rigidity,3,16467673
22,22.0,Breast cancer stage I,3,16467673
23,22.0,Visual impairment,3,16467673
24,22.0,Cough,3,16467673
25,22.0,Dyspnoea,3,16467673
